Kevin Trinh, PharmD, MBA, BCGP
Kevin Trinh, PharmD, MBA, BCGP, is a Director of Medical Outcomes & Analytics for Pfizer Medical Affairs. In this role, he collaborates with healthcare systems to develop clinical data analytics to address population health issues. He has a background in managed care and specialty pharmacy, with an emphasis on pharmacoeconomics, HEOR, and regulatory affairs. His research interests include formulary management, drug utilization review, and the implementation of clinical initiatives for healthcare networks. Prior to joining Pfizer, he worked for Community Health Network Specialty Pharmacy as the Outcomes and Performance Manager, where he partnered with pharmacy leaders and information system stakeholders to develop and execute core pharmacy KPI strategies. In his free time, he enjoys playing pickleball and spending time with his family.
Ralph Rewers, PharmD
Ralph Rewers obtained his BS in Pharmacy in 1980 and earned his PharmD in 1986 as one of the first "post-BS" PharmD graduates from the Purdue School of Pharmacy. He practiced hospital pharmacy for 13 years in northwest Indiana while also serving on the Purdue Pharmacy Alumni Board. Additionally, he was heavily involved in the Indiana State Pharmacy Association during his time in Indiana. He specialized in critical care medicine and mentored numerous pharmacy students from Purdue and Butler. He later moved to Tucson, Arizona, where he served as a clinical coordinator at Tucson Medical Center while also serving on the faculty at the University of Arizona.
In 1994, Ralph transitioned to the pharmaceutical industry, joining Pfizer as a clinical education consultant. He spent the next 30 years working in medical affairs, specifically in field medical (MSLs). In 1996, he became a field manager and went on to hold leadership positions at six companies—Pfizer, Amgen, BMS, AbbVie, AstraZeneca, and Gilead. Over his career, he led organizations as large as 250 people and played a key role in launching products exceeding $20 billion in sales. He also published white papers on field medical affairs and served as the initial lead for field medical at MAPS (Medical Affairs Professional Society).
Since retiring in November 2024, he has been traveling the U.S. in his RV and spending time on the slopes in his home state of Colorado. He remains an avid Boilermaker fan and attended last year's Final Four with the Boilers.
Cealia Tolliver, PharmD
Cealia Tolliver earned her Doctor of Pharmacy (PharmD) in 2024 from Purdue University College of Pharmacy. She currently serves as a Visiting Scientist Fellow within Eli Lilly and Company, supporting the Global Public Policy team. Her team develops policy positions and strategies across three sectors: state policy, federal policy, and international policy, providing expert insights and recommendations on healthcare policy affecting Lilly and key stakeholders, particularly related to pricing, affordability, and access. Cealia has previous experience working within Regulatory Policy and Intelligence team, as well as advertising and promotion during her time as a student. She also serves as an active member within the Indiana Pharmacy Association, serving on their Legislative and Regulatory Council as well as the Health Equity Council. Post-fellowship, Cealia hopes to grow within Corporate Affairs through environment shaping and advocacy. In her spare time, she coaches a 13s club volleyball team, attends hot yoga classes at Invoke, and travels. Despite now working full time in industry, she continues to work at her hometown community pharmacy where she was once a student pharmacist.
Megan Shieh, PharmD
Megan Shieh obtained her Doctor of Pharmacy from Chapman University School of Pharmacy in 2024. She is currently the first-year Global Regulatory Affairs fellow at Takeda Pharmaceuticals, where she works in the Gastrointestinal and Inflammation Therapeutic Area Unit. Prior to her fellowship, she completed rotations with the Food and Drug Administration Office of Regulatory Affairs and at Bristol Myers Squibb’s Global Regulatory Affairs unit. Her professional interests include obtaining the Regulatory Affairs Certification through the Regulatory Affairs Professionals Society, building upon her responsibilities in her fellowship, and mentoring pharmacy students. In her free time, she enjoys indoor bouldering, dancing, and solving crossword puzzles.
Josh Martin, PharmD
Josh Martin began his career at Novartis as a Commercial Post-doctoral Fellow, working across both Launch Excellence and Marketing Strategy. Following his fellowship, Josh took on the role of Senior Marketing Manager on the Cosentyx patient marketing team for its dermatology indications. During this time, he played a pivotal role in launching a new TV campaign featuring celebrity patient advocate Cyndi Lauper. Additionally, Josh contributed to the launch of the first new biologic treatment option for hidradenitis suppurativa (HS) patients in nearly a decade. His work on the award-winning "Shine a Light on HS" unbranded campaign resulted in an incremental 5,000 newly diagnosed patients within just six months, significantly surpassing established benchmarks.
After a year working on direct-to-consumer (DTC) marketing, Josh transitioned to the professional promotions side of the business. He has since been promoted to Associate Director, Marketing Strategist, where he helps shape both personal and non-personal strategies among dermatology providers in a competitive marketplace.
Prior to Novartis, Josh gained experience as a Medical Writer in the oncology space at Wunderman Thompson Health. He holds a Doctor of Pharmacy degree from Purdue University, earned in 2021. In his free time, Josh enjoys running, golfing, and reading. He currently resides in New York City.
Kwadwo Yeboah, PharmD
Kwadwo holds a BSc. in Biochemistry from Idaho State University and a PharmD from Purdue University College of Pharmacy. After pharmacy school, he pursued a fellowship in Global Regulatory Affairs at GlaxoSmithKline (GSK)/UNC Eshelman School of Pharmacy, after which he stayed on at GSK as a US Regulatory Lead in Oncology and eventually served as one of the Directors of the UNC/GSK Fellowship program.
Kwadwo is currently at Pfizer (formerly Seagen) as an Oncology Global Regulatory Lead (GRL), where he provides strategic regulatory advice aimed at streamlining the marketing authorization of oncology products. Kwadwo enjoys spending time with his family, and particularly adores watching his two sons fall in love with Soccer and Tennis.
Brooke Huang, PharmD
Brooke Huang obtained her Doctor of Pharmacy (PharmD) degree from Purdue University in 2003 and was recognized as a Kellogg Executive Scholar in Leadership in 2020. She was recently Senior Vice President of Global Product and Portfolio Strategy at Novocure, where she established the company’s first long-term strategic and commercialization plans for a medical device that treats cancer. She built and led US and Global Marketing, Market Planning & Research, Competitive Intelligence, Product Innovation, New Indication Planning and Program Management teams at the organization. In addition, she was a preceptor for Purdue PharmD students and started a Commercial PharmD Fellowship with IPhO. At Daiichi Sankyo, Brooke optimized lifecycle management and US and global commercialization strategies. She focused on medical affairs, driving education and communications strategies across cardiovascular and thrombosis areas while at Sanofi. Brooke started her career as a Rutgers Fellow at BMS in Medical Strategy. She is passionate about mentoring PharmD students and fellows with an interest in industry when she is not busy at the gym or chasing around her 2-year-old twin boys.
Jeff Czarnik, PharmD
Jeff Czarnik obtained his Doctor of Pharmacy (PharmD) degree from Purdue University College of Pharmacy in 2024. While at Purdue, he was actively involved in various organizations and previously served as president of Purdue's IPhO Chapter. After graduation, Jeff joined Eli Lilly as a contractor and now works as a Medical Omnichannel Education Manager in Immunology. In this role, he delivers scientifically relevant, evidence-based education and solutions to HCPs through omnichannel initiatives. Passionate about continuous learning and professional growth in medical affairs, Jeff is dedicated to expanding his expertise in the field. Outside of work, he enjoys staying active through weightlifting, biking, and volleyball, as well as various other hobbies like reading and home improvement projects.
Alexus Gordon, PharmD
Alexus Gordon graduated from Purdue College of Pharmacy in 2024. Throughout her time in college, she emphasized her career development, refining her communication skills, building her personal brand, and enhancing her professional presence. Alongside her technical experience, Alexus gained valuable industry exposure, beginning with an internship in medical affairs at Tarsus Pharmaceuticals, where she contributed to medical strategy through the development of in-field tools, advisory board presentations, and published patient experiences. During her APPE rotations, Alexus was a Business Science Analytics Extern at Vividion Therapeutics, collaborating closely with regulatory affairs and deepening her understanding of the drug development process. She also applied her clinical expertise by delivering a patient-perspective business landscape presentation for a therapeutic target of interest. This experience ultimately led to a full-time position at Vividion after graduation. Now, as a Clinical Project
Manager at Vividion Therapeutics, Alexus combines her clinical knowledge with her strong interpersonal skills to support cross-functional teams. She fosters strategic collaboration between preclinical and clinical groups, driving project goals forward and ensuring efficient execution. Her professional interests include leadership development, enhancing team communication, and mentorship. After relocating from Indiana to Southern California, Alexus enjoys soaking up the sun, walking her new puppy, and trying new cuisines with her husband.
Dr. Andrew Lake Wooton, PhD
Dr. A. Lake Wooten is a leader in the radiopharmaceutical industry, with over 12 years of experience spanning radioligand therapy (RLT) manufacturing and medical isotope production. He has worked on projects for several important therapeutic isotopes—including actinium-225, lead-212, and astatine-211, and his leadership has encompassed GMP manufacturing, technology transfer, technical operations, project management, radiochemistry expertise, and radiation safety. Dr. Wooten has helped establish 3 new facilities and lead high-impact projects, including as the founding Site Director for a multimillion-dollar RLT commercial manufacturing facility and as Sr. Scientific Project Manager for a leading radiopharmaceutical contract development and manufacturing organization (CDMO). Dr. Wooten has listed as Radiation Safety Officer (RSO) and as an Authorized User (AU) on licenses from the U.S. Nuclear Regulatory Commission (NRC). He has authored 17 publications and holds multiple advanced degrees, including a Ph.D. in Biomedical Engineering. A dedicated advocate for radiopharmaceuticals, Dr. Wooten is an ambassador with the patient-focused Oncidium Foundation and an active participant in industry organizations. Dr. Wooten has also contributed to education and training of future contributors to radiopharmaceuticals in his roles as Affiliate Faculty in the College of Pharmacy at Purdue University, as a preceptor for Pharm.D. students, as a consultant for a new M.S. program in Radiopharmaceutical Manufacturing at Purdue University, and as a mentor to numerous other interns, students, and young professionals during his career. Dr. Wooten is passionate about promoting radiopharmaceuticals in many ways, including: engaging the scientific community, participating in industry events, presenting to students, mentoring young professionals, and advocating for patients.
Jacob Martin, PharmD
Jacob Martin is currently a US Medical Strategy indication lead at Daiichi Sankyo, supporting the tumor agnostic indication of an antibody-drug conjugate. He was previously on the US Market Access Marketing team at Daiichi Sankyo, as well as at McCann Health in various Strategy and Consulting roles. Jacob received his PharmD from Purdue University and subsequently completed a Strategic Marketing Fellowship through the Rutgers Pharmaceutical Industry Fellowship program. Jacob resides in Seattle, WA and enjoys traveling with his wife, running marathons, and attending hockey games.
Michele Baber, PharmD
Michele received her Bachelor of Pharmacy degree from Purdue University and her Doctor of Pharmacy degree from the University of Cincinnati. She completed her residency at Holy Cross Hospital in Florida. Prior to joining industry, she practiced as a Clinical Pharmacy Coordinator establishing the first clinical pharmacy program for a mid-sized community hospital. Since joining industry, she has been involved in several product launches at Immunex, Amgen and AstraZeneca. As an Executive Medical Science Liaison she led Advisory Boards, established Clinical Trial Study Lead and Clinical Trial Sponsor roles, served as the Global MSL Ambassador, MSL lead for ASCO and led several smaller congresses, served as the Breast Cancer Skill Set Lead and mentor to new MSLs. She has also served on the Diversity and Inclusion Talent Workstream and led the MSL Clinical Trial Diversity and Inclusion Workstream. She has a passion for patient care and the ultimate delivery of new and improved medicines to patients…… ALL PATIENTS!
Outside of work, Michele enjoys hiking, cycling, traveling, playing music and spending time with friends and family..